Real-World Safety and Effectiveness of Up to 12 Months of Tralokinumab Treatment in Adults With Atopic Dermatitis Who Discontinued Dupilumab Due to Conjunctivitis

Skin · Published 2026-03-10 · DOI 10.25251/1jtrf706

Authors being retrieved — see the publisher record. https://doi.org/10.25251/1jtrf706

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Unanticipated Skin Discovery at the Lateral Thigh · Skin · 2026 · Same journal
Chronic Trichophyton indotineae Infections Mimicking Adult-Onset Atopic Dermatitis · Skin · 2026 · Same journal
Severe Psoriasis Leading to Scarring Alopecia of the Scalp Responding to Biologic Therapy · Skin · 2026 · Same journal
A Case of Erdheim-Chester Disease in a Patient with Langerhans Cell Histiocytosis · Skin · 2026 · Same journal
Eruptive Cutaneous Metastatic Leiomyosarcoma · Skin · 2026 · Same journal
Pilot Evaluation of the Efficacy and Safety of Xtressé™ Gummy-Based Nutraceutical Supplement in Women with Hair Loss · Skin · 2026 · Same journal
When to Reapply Moisturizers: Evidence-Based Intervals from a 24-Hour Hydration Study · Skin · 2026 · Same journal
Rethinking the Rule of Halves: A Centripetal Suturing Technique to Minimize Dog-Ear Formation · Skin · 2026 · Same journal
Restorative Oncodermatology: Piloting an Educational Pamphlet to Address Dermatologic Sequelae in Cancer Survivors · Skin · 2026 · Same journal
Early and Sustained Effects of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel · Skin · 2026 · Same journal